TY - JOUR AU - Кhyzhnyak, O. O. AU - Gogitidze, T. G. PY - 2021/08/17 Y2 - 2024/03/28 TI - PECULARITIES OF CARBOHYDRARE METABOLISM IN PATIENTS WITH PROLACTINOMAS DURING SUPRESSIVE AGONIST DOPAMINE’S THERAPY JF - Problems of Endocrine Pathology JA - PEP VL - 53 IS - 3 SE - DO - 10.21856/j-PEP.2015.3.09 UR - https://www.jpep.endocrinology.org.ua/index.php/1/article/view/432 SP - 67-76 AB - <p>The article presents data of carbohydrate metabolism at the stages of long-term (12months) suppressive therapy dopamine agonist cabergoline in 61 patients with prolactinomas. It was proved that the normalization of prolactin levels during therapy reduces fasting glucose, HbA1c of patients, independently of gender. Insulin levels become normal in men with prior hyperinsulinemia and overweight. Pharmacology-induced hypoprolaktinemya not lead to disorders of carbohydrate metabolism.</p> ER -